The market, which was valued at $0.85 billion in 2024, is projected to grow to $0.91 billion in 2025, representing a compound annual growth rate CAGR of 7.2%. The growth during this historic period ...

People with autoimmune skin diseases had significantly better cancer survival outcomes than others. Survival benefits were ...

The Society for Cardiovascular Angiography & Interventions (SCAI) has published new, evidence-based clinical practice guidelines to support the treatment of chronic venous disease (CVD), a common and ...

Rates of Raynaud phenomenon medication initiation are low among patients with SSc in the United States, with less than one-third receiving consistent treatment.

New consensus guidelines outline best practices for orthopedic management in Duchenne muscular dystrophy, focusing on ...

Panelists discuss how chronic neuroinflammation involves distinct mechanisms from acute relapses—including microglial ...

A new study by scientists at the University of Colorado Anschutz Medical Campus reveals that joint tissue from patients with ...

The AJMC® Atopic Dermatitis compendium is a comprehensive resource for clinical news and expert insights for the chronic skin condition that typically develops in early childhood.

Treatment Epinephrine is the primary medication used to treat anaphylaxis. It’s fast and effective at opening your airways and reducing other symptoms. Epinephrine is available as an auto-injector.

Medicines that fight bacteria, called antibiotics, are the main treatment for Lyme disease. It’s important to get treatment as early as possible to make a full recovery and avoid complications.

If your yeast infection didn’t respond to the first course of treatment, your doctor may prescribe long-term antifungals. This may include weekly oral or vaginal medications for up to 6 months.